tirzepatide lean mass monitoring
Doctors Warn Semaglutide Mitigates Muscle Loss
In the 2023 OASIS 4 trial, semaglutide users gained an average of 2.4 kg of lean mass while losing 16.6% of total body weight, indicating superior muscle preservation compared with tirzepatide. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult